Condition
Diabetes, Obesity
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Tu Salud Si Cuenta Behavioral Intervention
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 4 (1)
Trial Status
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT02597309Phase 4WithdrawnPrimary
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin
NCT01168765Not ApplicableCompletedPrimary
Tu Salud Si Cuenta: UT Community Outreach Program for Community-based Diabetes Prevention and Control.
Showing all 2 trials
Research Network
Common Treatments
- Tu Salud Si Cuenta Behavioral Intervention1
- Canagliflozin1
Active Sponsors
- The University of Texas Health Science Center, Houston1
- Joslin Diabetes Center1
Top Investigators
University of Texas Health Science Center at Houston School of Public Health-Brownsville Regional Campus